Skip to content

Clinical trials

Completed Phase 1/2 Cardiovascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 1/2 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20034
20082
20091
20101
20114
20121
20131
20151
20161
20171
20183
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Oslo2
Alexandra Cristina Senegaglia1
Colorado State University1
First Affiliated Hospital of Harbin Medical University1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Indiana University1
Lacy Alexander1
National Heart, Lung, and Blood Institute (NHLBI)1
Nemours Children's Clinic1
RMJ Holdings, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases23
Hypertension5
Heart Diseases4
Atherosclerosis3
Coronary Artery Disease2
Heart Defects, Congenital2
Hypoxia2
Inflammation2
Myocardial Infarction2
Obesity2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.